ABVC BioPharma, Inc. (ABVC)
0.8701
-0.04
(-4.43%)
USD |
NASDAQ |
Nov 19, 15:56
ABVC BioPharma Shareholders Equity (Quarterly) : 13.05M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 13.05M |
| June 30, 2026 | 10.29M |
| March 31, 2026 | 10.77M |
| December 31, 2025 | 11.11M |
| September 30, 2025 | 12.06M |
| June 30, 2025 | 7.014M |
| March 31, 2025 | 5.404M |
| December 31, 2024 | 1.226M |
| September 30, 2024 | 8.358M |
| June 30, 2024 | 8.294M |
| March 31, 2024 | 8.018M |
| December 31, 2023 | 1.554M |
| September 30, 2023 | 9.777M |
| June 30, 2023 | 0.5236M |
| March 31, 2023 | 2.799M |
| December 31, 2022 | 4.453M |
| September 30, 2022 | 7.499M |
| June 30, 2022 | 11.14M |
| March 31, 2022 | 9.458M |
| December 31, 2021 | |
| September 30, 2021 | 11.08M |
| June 30, 2021 | 4.149M |
| March 31, 2021 | 5.506M |
| December 31, 2020 | 6.599M |
| September 30, 2020 | 2.850M |
| Date | Value |
|---|---|
| June 30, 2020 | 2.538M |
| March 31, 2020 | 2.701M |
| December 31, 2019 | 3.912M |
| September 30, 2019 | 4.955M |
| June 30, 2019 | -3.320M |
| March 31, 2019 | -5.762M |
| December 31, 2018 | -5.658M |
| September 30, 2018 | -2.449M |
| June 30, 2018 | -2.238M |
| March 31, 2018 | -1.933M |
| December 31, 2017 | -1.757M |
| September 30, 2017 | -1.393M |
| June 30, 2017 | -1.048M |
| December 31, 2016 | -6.520M |
| September 30, 2016 | -6.379M |
| June 30, 2016 | -8.473M |
| March 31, 2016 | -9.129M |
| December 31, 2015 | 0.0649M |
| September 30, 2015 | 0.0291M |
| June 30, 2015 | 0.0299M |
| March 31, 2015 | 0.0314M |
| December 31, 2014 | 0.0295M |
| September 30, 2014 | 0.0306M |
| June 30, 2014 | -1.880M |
| March 31, 2014 | -1.880M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| T2 Biosystems, Inc. | -- |
| Anika Therapeutics, Inc. | 137.58M |
| Perspective Therapeutics, Inc. | 294.68M |
| MiMedx Group, Inc. | 211.08M |
| Abbott Laboratories | 51.03B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.30M |
| Total Liabilities (Quarterly) | 8.554M |
| Debt to Equity Ratio | 0.3057 |
| Current Ratio | 0.1953 |
| Net Debt Paydown Yield | -1.18% |